These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36865275)

  • 1. The La Crosse virus class II fusion glycoprotein
    Thannickal SA; Spector SN; Stapleford KA
    bioRxiv; 2023 Feb; ():. PubMed ID: 36865275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The La Crosse virus class II fusion glycoprotein
    Thannickal SA; Spector SN; Stapleford KA
    J Virol; 2023 Aug; 97(8):e0081923. PubMed ID: 37578236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structurally Conserved Domains between Flavivirus and Alphavirus Fusion Glycoproteins Contribute to Replication and Infectious-Virion Production.
    Rangel MV; Catanzaro N; Thannickal SA; Crotty KA; Noval MG; Johnson KEE; Ghedin E; Lazear HM; Stapleford KA
    J Virol; 2022 Jan; 96(2):e0177421. PubMed ID: 34757841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chikungunya virus E1 glycoprotein fusion loop and hinge alter glycoprotein dynamics leading to cell and host specific changes in infectivity.
    Thannickal SA; Battini L; Spector SN; Noval MG; Álvarez DE; Stapleford KA
    bioRxiv; 2023 Nov; ():. PubMed ID: 37961096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the chikungunya virus E1 glycoprotein domain II and hinge influence E2 conformation, infectivity, and virus-receptor interactions.
    Thannickal SA; Battini L; Spector SN; Noval MG; Álvarez DE; Stapleford KA
    J Virol; 2024 Jul; 98(7):e0067924. PubMed ID: 38842335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Mutations in the Fusion Peptide Region of La Crosse Virus Attenuate Neuroinvasion and Confer Protection against Encephalitis.
    Hollidge BS; Salzano MV; Ibrahim JM; Fraser JW; Wagner V; Leitner NE; Weiss SR; Weber F; González-Scarano F; Soldan SS
    Viruses; 2022 Jul; 14(7):. PubMed ID: 35891445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. La Crosse virus (LACV) Gc fusion peptide mutants have impaired growth and fusion phenotypes, but remain neurotoxic.
    Soldan SS; Hollidge BS; Wagner V; Weber F; González-Scarano F
    Virology; 2010 Sep; 404(2):139-47. PubMed ID: 20553924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Ionophores Active against La Crosse Virus Identified through Rapid Antiviral Screening.
    Sandler ZJ; Firpo MR; Omoba OS; Vu MN; Menachery VD; Mounce BC
    Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32284379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging Chikungunya Virus Variants at the E1-E1 Interglycoprotein Spike Interface Impact Virus Attachment and Inflammation.
    Rangel MV; McAllister N; Dancel-Manning K; Noval MG; Silva LA; Stapleford KA
    J Virol; 2022 Feb; 96(4):e0158621. PubMed ID: 34935436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two Conserved Phenylalanine Residues in the E1 Fusion Loop of Alphaviruses Are Essential for Viral Infectivity.
    Lucas CJ; Davenport BJ; Carpentier KS; Tinega AN; Morrison TE
    J Virol; 2022 May; 96(9):e0006422. PubMed ID: 35416719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of infectivity of insect cell-derived La Crosse Virus by human serum.
    Cruz MA; Parks GD
    Virus Res; 2021 Jan; 292():198228. PubMed ID: 33188797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenesis of the La Crosse Virus glycoprotein supports a role for Gc (1066-1087) as the fusion peptide.
    Plassmeyer ML; Soldan SS; Stachelek KM; Roth SM; Martín-García J; González-Scarano F
    Virology; 2007 Feb; 358(2):273-82. PubMed ID: 17027056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of La Crosse Virus Infection in Aedes albopictus Mosquitoes Following Larval Exposure to Coffee Extracts.
    Eastep NE; Albert RE; Anderson JR
    Front Physiol; 2012; 3():66. PubMed ID: 22470349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elongin C Contributes to RNA Polymerase II Degradation by the Interferon Antagonist NSs of La Crosse Orthobunyavirus.
    Schoen A; Lau S; Verbruggen P; Weber F
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31941775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A recombinant chimeric La Crosse virus expressing the surface glycoproteins of Jamestown Canyon virus is immunogenic and protective against challenge with either parental virus in mice or monkeys.
    Bennett RS; Gresko AK; Nelson JT; Murphy BR; Whitehead SS
    J Virol; 2012 Jan; 86(1):420-6. PubMed ID: 22013033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirtuin Inhibitors Are Broadly Antiviral against Arboviruses.
    Hackett BA; Dittmar M; Segrist E; Pittenger N; To J; Griesman T; Gordesky-Gold B; Schultz DC; Cherry S
    mBio; 2019 Jul; 10(4):. PubMed ID: 31289184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. La Crosse virus infectivity, pathogenesis, and immunogenicity in mice and monkeys.
    Bennett RS; Cress CM; Ward JM; Firestone CY; Murphy BR; Whitehead SS
    Virol J; 2008 Feb; 5():25. PubMed ID: 18267012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impacts of climate, land use, and biological invasion on the ecology of immature Aedes mosquitoes: implications for La Crosse emergence.
    Leisnham PT; Juliano SA
    Ecohealth; 2012 Jun; 9(2):217-28. PubMed ID: 22692799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome sequence analysis of La Crosse virus and in vitro and in vivo phenotypes.
    Bennett RS; Ton DR; Hanson CT; Murphy BR; Whitehead SS
    Virol J; 2007 May; 4():41. PubMed ID: 17488515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure, function, and evolution of the Orthobunyavirus membrane fusion glycoprotein.
    Hellert J; Aebischer A; Haouz A; Guardado-Calvo P; Reiche S; Beer M; Rey FA
    Cell Rep; 2023 Mar; 42(3):112142. PubMed ID: 36827185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.